Three-dimensional evaluation of chemotherapy response in malignant pleural mesothelioma

European Journal of Radiology

Volumn 74, Issue 1, 2010, Pages 130-135

  Ak, Guntulu ^a   Metintas, Muzaffer ^a   Metintas, Selma ^a   Yildirim, Huseyin ^a   Ozkan, Ragip ^a   Ozden, Hilmi ^a  

^a ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Cavalieri principle; Chemotherapy response criteria; Malignant pleural mesothelioma; Volumetric method

Indexed keywords

CHEMOTHERAPY RESPONSE; COMPUTED TOMOGRAPHY; EVALUATION CRITERIA; MALIGNANT PLEURAL MESOTHELIOMAS; MEDIAN SURVIVAL; NON-SPHERICAL; PROGRESSIVE DISEASE; SOLID TUMORS; TUMOR GROWTH; TUMOR RESPONSE; TUMOR VOLUMES; VOLUMETRIC METHODS; WORLD HEALTH ORGANIZATION;

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; GROWTH RATE; VOLUME MEASUREMENT;

TUMORS;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CONE BEAM COMPUTED TOMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR VOLUME; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MESOTHELIOMA; MIDDLE AGED; NEOPLASM STAGING; PLEURAL NEOPLASMS; PROGNOSIS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 77950045306     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2009.02.002     Document Type: Article

References (25)

1. Metintas S., Metintas M., Ucgun I., and Oner U. Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area. Chest 122 6 (2002) 2224-2229
2. Robinson B.W.S., Musk A.W., and Lake A.R. Malignant mesothelioma. Lancet 366 9483 (2005) 397-408
3. Tomek S., and Manegold C. Chemotherapy for malignant pleural mesothelioma: past results and recent developments. Lung Cancer 45S (2004) S103-S119
4. Vogelzang N.J., Rusthoven J.J., Symanowski J., et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 21 14 (2003) 2636-2644
5. van Meerbeeck J.P., Gaafar R., Manegold C., et al. Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada. J Clin Oncol 23 28 (2005) 6881-6889
6. Miller A.B., Hoogstraten B., Staquet M., and Winkler A. Reporting results of cancer treatment. Cancer 47 1 (1981) 207-214
7. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 3 (2000) 205-216
8. Monetti F., Casanova S., Grasso A., et al. Inadequacy of the new response evaluation criteria in solid tumors (RECIST) in patients with malignant pleural mesothelioma: report of four cases. Lung Cancer 43 1 (2004) 71-74
9. Van Klaveren R.J., Aerts J.G.J.V., de Bruin H.G., et al. Inadequacy of RECIST criteria for the evaluation of response in patients with malignant pleural mesothelioma. Lung Cancer 43 1 (2004) 63-69
10. Byrne M.J., and Nowak A.K. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 15 2 (2004) 257-260
11. Armato III S.G., Oxnard G.R., MacMahon H., et al. Measurement of mesothelioma on thoracic CT scans: a comparison of manuel and computer-assisted techniques. Med Phys 31 5 (2004) 1105-1115
12. Oxnard G.R., Armato III S.G., and Kindler H.L. Modeling of mesothelioma growth demonstrates weaknesses of current response criteria. Lung Cancer 52 2 (2006) 141-148
13. Ozden H., Ak G., Metintas S., et al. Relationship between tumor size of malignant pleural mesothelioma and its response to chemotherapy. J Health Sci 53 1 (2007) 23-30
14. Gundersen H.J.G., and Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J Microsc 147 3 (1987) 229-263
15. Roberts N., Cruz-Orive L.M., Reid N.M.K., et al. Unbiased estimation of human body composition by the Cavalieri method using magnetic resonance imaging. J Microsc 171 3 (1993) 239-253
16. Sahin B., and Ergur H. Assessment of the optimum section thickness for the estimation of liver volume using magnetic resonance images: a stereological gold standard study. Eur J Radiol 57 1 (2006) 96-101
17. Odaci E., Sahin B., Sonmez O.F., et al. Rapid estimation of the vertebral body volume: a combination of the Cavalieri principle and computed tomography images. Eur J Radiol 48 3 (2003) 316-326
18. Jelsing J., Rostrup E., Markenroth K., et al. Assessment of in vivo MR imaging compared to physical sections in vitro-a quantitative study of brain volumes using stereology. NeuroImage 26 1 (2005) 57-65
19. Metintas M., Ak G., Erginel S., et al. A retrospective analysis of malignant pleural mesothelioma patients treated either with chemotherapy or best supportive care between 1990 and 2005: a single institution experience. Lung cancer 55 3 (2007) 379-387
20. Metintas M., Ucgun I., Elbek O., et al. Computed tomography features in malignant pleural mesothelioma and other commonly seen pleural disease. Eur J Radiol 41 1 (2002) 1-9
21. Prasad S.R., Jhaveri K.S., Saini S., et al. CT tumor measurement for therapeutic response assessment: comparison of unidimensional, bidimensional, and volumetric techniques-initial observations. Radiology 225 2 (2002) 416-419
22. Zhao B., Schwartz L.H., Liu F., et al. Development of a computer method for volumetric response assessment in mesothelioma. Lung Cancer 54 Suppl. 1 (2006) 20
23. James K., Eisenhauer E., Christian M., et al. Measuring response in solid tumors: unidimensional versus bidimensional measurement. J Natl Cancer Inst 91 6 (1999) 523-528
24. Armato III S.G., Oxnard G.R., Kocherginsky M., et al. Evaluation of semiautomated measurements of mesothelioma tumor thickness on CT scans. Acad Radiol 12 10 (2005) 1301-1309
25. Ceresoli G.L., Chiti A., Zucali P.A., et al. Early evaluation in malignant pleural mesothelioma by positron emission tomography with (18F) fluorodeoxyglucose. J Clin Oncol 24 28 (2006) 4587-4593